These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18769342)

  • 1. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study.
    Huang W; Kanehira K; Drew S; Pier T
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):12-7. PubMed ID: 18769342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
    Geramizadeh B; Ravanshad M; Rahsaz M
    Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High endogenous avidin binding activity: an inexpensive and readily available marker for the differential diagnosis of kidney neoplasms.
    Kanehira K; Hu J; Pier T; Sebree L; Huang W
    Int J Clin Exp Pathol; 2008 Jan; 1(5):435-9. PubMed ID: 18787626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
    Wang HY; Mills SE
    Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
    Liu L; Qian J; Singh H; Meiers I; Zhou X; Bostwick DG
    Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
    Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
    Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
    Kuroda N; Kanomata N; Yamaguchi T; Imamura Y; Ohe C; Sakaida N; Hes O; Michal M; Shuin T; Lee GH
    Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
    Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
    Gokden N; Gokden M; Phan DC; McKenney JK
    Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
    Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
    Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
    Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics.
    Carvalho JC; Wasco MJ; Kunju LP; Thomas DG; Shah RB
    Histopathology; 2011 Jan; 58(2):169-79. PubMed ID: 21323945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma.
    Li G; Cuilleron M; Gentil-Perret A; Cottier M; Passebosc-Faure K; Lambert C; Genin C; Tostain J
    Clin Cancer Res; 2003 Dec; 9(17):6441-6. PubMed ID: 14695146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.
    Avery AK; Beckstead J; Renshaw AA; Corless CL
    Am J Surg Pathol; 2000 Feb; 24(2):203-10. PubMed ID: 10680888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
    Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.